African American women have lower breast cancer survival rates than white women and University of California, San Francisco (UCSF) scientists are studying why – as well as how to increase their life spans.

It’s a matter of fairness: members of all ethnic groups should have the opportunity to participate in clinical trials. And it’s a matter of soundness, too: medical advancements must be tested in as many different people with as many different genetic makeups as possible.

UCSF professor Goerge Sawaya, MD, a member of the  U.S. Preventive Services Task Force that developed updated recommendations on breast cancer screening, discusses the rationale and the role of science in advancing change in clinical practice in this video.

One dose of radiation during surgery for early breast cancer is as effective as six weeks of standard treatment – which could save as much as $1.5 billion in the United States over five years.

A new way to study and treat breast cancer being launched at the University of California, San Francisco (UCSF) in October will screen women for the disease and provide them with individual assessments of their risk of developing the cancer.    

October marks Breast Cancer Awareness Month, an opportune time to take stock of some of the recent progress being made at UCSF, home to one of the preeminent cancer centers in the nation.

Brain tumor specimens taken from neurosurgery cases at the University of California, San Francisco (UCSF) Medical Center has given scientists a new window on the transformation that occurs as healthy brain cells begin to form tumors

UCSF welcomes hundreds of first-year students, who are members of an entering class that hale from 44 states and 55 countries in addition to the United States and consist of 66 percent women. 

Some of the biggest names in the field of global health came to UCSF recently to discuss to work together to improve the education of health professionals in the United States and around the world.